Matthew Stevenson1, Ankita Srivastava1, Jenny Lee1, Christopher Hall1, Thomas Palaia1,2, Raymond Lau3, Collin Brathwaite4, Louis Ragolia5,6. 1. Department of Biomedical Research, NYU Long Island School of Medicine, NYU Langone Hospital-Long Island, 101 Mineola Blvd. Suite 4-003, Mineola, NY, 11501, USA. 2. Department of Foundations of Medicine, NYU Long Island School of Medicine, 101 Mineola Blvd, Mineola, NY, 11501, USA. 3. Department of Endocrinology, NYU Langone Hospital-Long Island, 101 Mineola Blvd. Suite 2-009, Mineola, NY, 11501, USA. 4. Department of Surgery, NYU Langone Hospital-Long Island, 222 Station Plaza, Suite 300, Mineola, NY, 11501, USA. 5. Department of Biomedical Research, NYU Long Island School of Medicine, NYU Langone Hospital-Long Island, 101 Mineola Blvd. Suite 4-003, Mineola, NY, 11501, USA. Louis.Ragolia@NYULangone.org. 6. Department of Foundations of Medicine, NYU Long Island School of Medicine, 101 Mineola Blvd, Mineola, NY, 11501, USA. Louis.Ragolia@NYULangone.org.
Abstract
PURPOSE: Understanding the effects of Roux-en-Y gastric bypass (RYGB) and vertical sleeve gastrectomy (VSG) on adipose tissue physiology is important for the treatment of obesity-related metabolic disorders. By using robust mouse models of bariatric surgery that closely resemble those performed in humans, we can compare the effects of RYGB and VSG on adipose physiology in the absence of post-operative confounds such as diet and lifestyle changes. MATERIALS AND METHODS: RYGB and VSG were compared using a diet-induced mouse model of obesity. High-fat diet (HFD) was administered post-operatively and changes to white and brown adipose tissue were evaluated, along with alterations to weight, glucose homeostasis, dyslipidemia, and insulin sensitivity. RESULTS: After prolonged exposure to high-fat diet post-operatively, RYGB was effective in achieving sustained weight loss, while VSG unexpectedly accelerated weight gain rates. The resolution of obesity-related comorbidities such as glucose and insulin intolerance, dyslipidemia, and insulin sensitivity was improved after RYGB, but not for VSG. In RYGB, there were improvements to the function and health of white adipose tissue, enhanced brown adipose metabolism, and the browning of subcutaneous white adipose tissue, with no comparable changes seen for these factors after VSG. Some markers of systemic inflammation improved after both RYGB and VSG. CONCLUSION: There are significantly different effects between RYGB and VSG when HFD is administered post-operatively and robust mouse models of bariatric surgery are used. RYGB resulted in lasting physiological and metabolic changes but VSG showed little difference from that of its sham-operated, DIO counterpart.
PURPOSE: Understanding the effects of Roux-en-Y gastric bypass (RYGB) and vertical sleeve gastrectomy (VSG) on adipose tissue physiology is important for the treatment of obesity-related metabolic disorders. By using robust mouse models of bariatric surgery that closely resemble those performed in humans, we can compare the effects of RYGB and VSG on adipose physiology in the absence of post-operative confounds such as diet and lifestyle changes. MATERIALS AND METHODS: RYGB and VSG were compared using a diet-induced mouse model of obesity. High-fat diet (HFD) was administered post-operatively and changes to white and brown adipose tissue were evaluated, along with alterations to weight, glucose homeostasis, dyslipidemia, and insulin sensitivity. RESULTS: After prolonged exposure to high-fat diet post-operatively, RYGB was effective in achieving sustained weight loss, while VSG unexpectedly accelerated weight gain rates. The resolution of obesity-related comorbidities such as glucose and insulin intolerance, dyslipidemia, and insulin sensitivity was improved after RYGB, but not for VSG. In RYGB, there were improvements to the function and health of white adipose tissue, enhanced brown adipose metabolism, and the browning of subcutaneous white adipose tissue, with no comparable changes seen for these factors after VSG. Some markers of systemic inflammation improved after both RYGB and VSG. CONCLUSION: There are significantly different effects between RYGB and VSG when HFD is administered post-operatively and robust mouse models of bariatric surgery are used. RYGB resulted in lasting physiological and metabolic changes but VSG showed little difference from that of its sham-operated, DIO counterpart.
Authors: Bestoun Ahmed; Wendy C King; William Gourash; Steven H Belle; Amanda Hinerman; Alfons Pomp; Greg Dakin; Anita P Courcoulas Journal: Surgery Date: 2018-08-20 Impact factor: 3.982
Authors: G Nosso; E Griffo; M Cotugno; G Saldalamacchia; R Lupoli; G Pacini; G Riccardi; L Angrisani; B Capaldo Journal: Horm Metab Res Date: 2016-01-20 Impact factor: 2.936
Authors: David Benaiges; Albert Goday; Jose M Ramon; Elisa Hernandez; Manuel Pera; Juan F Cano Journal: Surg Obes Relat Dis Date: 2011-03-17 Impact factor: 4.734
Authors: Ankita Srivastava; Matthew Stevenson; Jenny Lee; Christopher Hall; Thomas Palaia; Chaohui Lisa Zhao; Raymond Lau; Collin Brathwaite; Louis Ragolia Journal: Obes Surg Date: 2022-04-14 Impact factor: 3.479
Authors: Margaret S Bohm; Laura M Sipe; Madeline E Pye; Matthew J Davis; Joseph F Pierre; Liza Makowski Journal: Cancer Metastasis Rev Date: 2022-07-23 Impact factor: 9.237